Published online Mar 15, 2022. doi: 10.4239/wjd.v13.i3.129
Peer-review started: February 28, 2021
First decision: July 15, 2021
Revised: September 14, 2021
Accepted: February 22, 2022
Article in press: February 22, 2022
Published online: March 15, 2022
Core Tip: Diagnosing insulin resistance in Polycystic ovary syndrome is of crucial importance for better management and prevention of complications. Seeking of an easy-to-detect surrogate marker of insulin resistance represents a promising approach for maximizing treatment outcomes. This review highlights markers of insulin resistance already used in women with Polycystic ovary syndrome, including new markers recently reported in literature, and establishes a new classification of them.